Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress
Authors
Keywords
-
Journal
Clinical Psychopharmacology and Neuroscience
Volume 19, Issue 3, Pages 423-433
Publisher
Korean College of Neuropsychopharmacology
Online
2021-07-23
DOI
10.9758/cpn.2021.19.3.423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment-Resistant depression enhances risks of dementia and alzheimer's disease: A nationwide longitudinal study
- (2020) Yee-Lam E. Chan et al. JOURNAL OF AFFECTIVE DISORDERS
- Cerebrospinal fluid and serum d-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease
- (2020) Tommaso Nuzzo et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials
- (2019) Chun-Hung Chang et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Alzheimer disease and aducanumab: adjusting our approach
- (2019) Dennis J. Selkoe Nature Reviews Neurology
- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
- (2019) Chieh-Hsin Lin et al. Frontiers in Psychiatry
- Diabetes as a risk factor for Alzheimer’s disease in the Middle East and its shared pathological mediators
- (2019) Richard L. Jayaraj et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brain Stimulation in Alzheimer's Disease
- (2018) Chun-Hung Chang et al. Frontiers in Psychiatry
- A Candidate Plasma Protein Classifier to Identify Alzheimer's Disease
- (2018) Xuemei Zhao et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
- (2017) Lídia Blanco-Silvente et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
- (2017) John T O’Brien et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease
- (2017) Ana García-Blanco et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Targeting Free Radicals in Oxidative Stress-Related Human Diseases
- (2017) Patrik Poprac et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Alzheimer’s disease prevention: from risk factors to early intervention
- (2017) Marta Crous-Bou et al. Alzheimers Research & Therapy
- Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators
- (2017) Lulu Yao et al. NEURAL PLASTICITY
- 2016 Alzheimer's disease facts and figures
- (2016) Alzheimers & Dementia
- The Benefits of Exercise and Metabolic Interventions for the Prevention and Early Treatment of Alzheimer's Disease
- (2016) Ewelina Maliszewska-Cyna et al. Current Alzheimer Research
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
- (2016) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- CSF d-serine concentrations are similar in Alzheimer's disease, other dementias, and elderly controls
- (2016) Elisanne A.L.M. Biemans et al. NEUROBIOLOGY OF AGING
- Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?
- (2016) P. Steullet et al. SCHIZOPHRENIA RESEARCH
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
- (2016) Rik Vandenberghe et al. Alzheimers Research & Therapy
- Therapies for Prevention and Treatment of Alzheimer’s Disease
- (2016) J. Mendiola-Precoma et al. Biomed Research International
- Abnormality in glutamine–glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study
- (2016) K Hashimoto et al. Translational Psychiatry
- Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
- (2015) Sid E. O'Bryant et al. Alzheimers & Dementia
- Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
- (2015) Celeste M. Karch et al. BIOLOGICAL PSYCHIATRY
- Where is hippocampal activity in the cascade of Alzheimer’s disease biomarkers?
- (2015) Howard J. Aizenstein et al. BRAIN
- Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression
- (2015) Willem Huijbers et al. BRAIN
- Socio-economic Aspects of Alzheimer's Disease
- (2015) Petra Maresova et al. Current Alzheimer Research
- Effects of noninvasive brain stimulation on cognitive function in healthy aging and Alzheimer's disease: a systematic review and meta-analysis
- (2015) Wan-Yu Hsu et al. NEUROBIOLOGY OF AGING
- Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
- (2015) Sagar H. Barage et al. NEUROPEPTIDES
- d-serine levels in Alzheimer’s disease: implications for novel biomarker development
- (2015) C Madeira et al. Translational Psychiatry
- Early detection of dementia in the community under a community-based integrated care system
- (2014) Yohko Maki et al. Geriatrics & Gerontology International
- The role of N-methyl-D-aspartate receptor in Alzheimer's disease
- (2014) Junsi Zhang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Targeting the Prodromal Stage of Alzheimer’s Disease: Bioenergetic and Mitochondrial Opportunities
- (2014) Charles C. Caldwell et al. Neurotherapeutics
- Oxidative stress in Alzheimer’s disease
- (2014) Zhichun Chen et al. Neuroscience Bulletin
- The future of blood-based biomarkers for Alzheimer's disease
- (2013) Kim Henriksen et al. Alzheimers & Dementia
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
- (2013) Parminder Raina et al. ANNALS OF INTERNAL MEDICINE
- Much of late life cognitive decline is not due to common neurodegenerative pathologies
- (2013) Patricia A. Boyle et al. ANNALS OF NEUROLOGY
- The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives
- (2013) Russell H. Swerdlow et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mitochondrial permeability transition pore is a potential drug target for neurodegeneration
- (2013) Valasani Koteswara Rao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Social Isolation Exacerbates Schizophrenia-Like Phenotypes via Oxidative Stress in Cortical Interneurons
- (2013) Zhihong Jiang et al. BIOLOGICAL PSYCHIATRY
- Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2013) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- Enfermedad de Alzheimer y deterioro cognitivo asociado a la diabetes mellitus de tipo 2: relaciones e hipótesis
- (2013) R.O. Domínguez et al. NEUROLOGIA
- A cholinergic trigger drives learning-induced plasticity at hippocampal synapses
- (2013) Dai Mitsushima et al. Nature Communications
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer’s disease
- (2012) A-Ryeong Gwon et al. AGING CELL
- How Nox2-Containing NADPH Oxidase Affects Cortical Circuits in the NMDA Receptor Antagonist Model of Schizophrenia
- (2012) Xin Wang et al. ANTIOXIDANTS & REDOX SIGNALING
- Metal dyshomeostasis and oxidative stress in Alzheimer’s disease
- (2012) Mark A. Greenough et al. NEUROCHEMISTRY INTERNATIONAL
- Neuropsychiatric symptoms in Alzheimer’s disease
- (2011) Constantine G. Lyketsos et al. Alzheimers & Dementia
- Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease
- (2011) P. Hemachandra Reddy BRAIN RESEARCH
- Dysregulated phosphorylation of Ca2+/calmodulin-dependent protein kinase II-α in the hippocampus of subjects with mild cognitive impairment and Alzheimer’s disease
- (2011) Lindsay C. Reese et al. JOURNAL OF NEUROCHEMISTRY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia
- (2011) Susan B. Powell et al. NEUROPHARMACOLOGY
- Glutamate signaling in the pathophysiology and therapy of schizophrenia
- (2011) Chieh-Hsin Lin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Basic mechanisms of neurodegeneration: a critical update
- (2010) Kurt A. Jellinger JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- NMDA-Mediated Ca2+ Influx Drives Aberrant Ryanodine Receptor Activation in Dendrites of Young Alzheimer's Disease Mice
- (2010) I. Goussakov et al. JOURNAL OF NEUROSCIENCE
- Intracellular Redox State Alters NMDA Receptor Response during Aging through Ca2+/Calmodulin-Dependent Protein Kinase II
- (2010) K. Bodhinathan et al. JOURNAL OF NEUROSCIENCE
- Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
- (2010) John T O’Brien et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- CSF biomarkers predict a more malignant outcome in Alzheimer disease
- (2010) A. K. Wallin et al. NEUROLOGY
- Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model
- (2010) H. Du et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease
- (2009) Mark P. Mattson Annals of the New York Academy of Sciences
- Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
- (2009) Bayani Uttara et al. Current Neuropharmacology
- Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
- (2009) Pieter Jelle Visser et al. LANCET NEUROLOGY
- Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
- (2009) Juan E Belforte et al. NATURE NEUROSCIENCE
- Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration
- (2009) Nevena V. Radonjić et al. NEUROPHARMACOLOGY
- Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses
- (2008) Sofia Papadia et al. NATURE NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started